Neopharm: Among the Top Bioprocessing Solutions Providers 2023
We are thrilled to share that Neopharm has been recognized for its excellence in GMP analytical testing and commitment to innovation in the biopharmaceutical industry. For over 30 years, Neopharm has been empowering life sciences with innovative analytical services tailored to meet the evolving demands of the industry.
Our strategic integration of Neopharm Labs, Averica Discovery Services (now Neopharm Boston), and MS Pharma (now Neopharm Laval) further demonstrates our commitment to expanding our services and meeting our partners' needs. Together, we stand as a united force, combining strengths and legacies to lead the industry.
“Renowned for our customer-centric approach, we serve organizations in North America and Europe, where our expertise in good manufacturing practice (GMP) testing ensures superior product quality and consistency across diverse specifications and regulatory mandates.” — Yvan Côté President and General Manager at Neopharm
At the beginning of this year, we introduced our Life Sciences business unit, which offers a comprehensive suite of services backed by a team of highly skilled scientists and industry experts proficient in a range of analytical technologies. From biological testing solutions to ad-hoc investigations, we support our clients in shaping the future of the life sciences industry through innovation.
Explore more about our journey, expansion, and service diversification in the biopharmaceutical industry.
Read the full article here.
Looking for tailored analytical expertise?
Discover how Neopharm Life Sciences can support your journey toward groundbreaking discoveries and successful product development.Contact us today
Join the 1,000+ scientists who have our blueprint.
Use our 12-step blueprint, avoid settlement delays, and get testing dome sooner.Download for free